Latest news

Our latest news keeping you up-to-date with our fundraising and campaigning stories and life-saving research breakthroughs.

Media enquiries: please contact communications@leukaemiauk.org.uk or call us on +44 (0)20 8189 9877.

Research Blog: A new target for paediatric AML

29 Jul 2026 Research

Research Blog: A new target for paediatric AML

In May this year one of our Leukaemia UK funded John Goldman Fellows, Dr Noelia Che, published a new paper along with her colleagues: MCL1 inhibition to enhance the efficacy...

A decade on: Dr Javier Redondo Muñoz continues to shape the future of Leukaemia research

18 May 2026 Research

A decade on: Dr Javier Redondo Muñoz continues to shape the future of Leukaemia research

Ten years after joining the second cohort of Leukaemia UK’s John Goldman Fellowships (JGF), Dr Javier Redondo Muñoz is continuing to shape the future of leukaemia research. Now leading his own team in...

Sign up to our newsletter

Keep up to date with our latest news & updates about our work

Can the new Scottish and Welsh parliaments turn ambition into progress for people affected by leukaemia?

22 Jul 2026 Policy

Can the new Scottish and Welsh parliaments turn ambition into progress for people affected by leukaemia?

In May this year, elections in Scotland and Wales set the course for Holyrood and the Senedd over the next...

The National Cancer Plan: what does it mean for people with leukaemia?

11 Feb 2026 Policy

The National Cancer Plan: what does it mean for people with leukaemia?

The Government’s new National Cancer Plan for England, which launched on World Cancer Day 2026, marks the most significant progress...

The latest developments and our response

26 Jan 2026 Policy

The latest developments and our response

The government is set to launch the National Cancer Plan for England on 4th February. We are urging policymakers to...

Improving access to life-changing treatment – Leukaemia UK’s role in the approval of Aucatzyl

25 Nov 2025 Policy

Improving access to life-changing treatment – Leukaemia UK’s role in the approval of Aucatzyl

Today, NICE announced its recommendation for Aucatzyl (obecabtagene autoleucel), a CAR-T therapy, to be made available on the NHS for...

1 in 4 leukaemia patients in England experiences an avoidable delay in diagnosis

18 Sep 2025 Policy

1 in 4 leukaemia patients in England experiences an avoidable delay in diagnosis

A first of its kind study, commissioned by Leukaemia UK, has revealed that a quarter (26%) of leukaemia patients in...

The first ever leukaemia-dedicated pathway to improve diagnosis, treatment and care

08 Jul 2025 Policy

The first ever leukaemia-dedicated pathway to improve diagnosis, treatment and care

The Best Practice Timed Pathway We’re delighted to share that Leukaemia UK, in partnership with Lymphoma Action and Myeloma UK,...

Together we are changing lives – Here’s how your support is making it happen

03 Jul 2025 Policy

Together we are changing lives – Here’s how your support is making it happen

At this point in our advocacy journey, we wanted to share an update to you, our supporters, on everything we've...

Leukaemia UK calls upon government to increase blood testing capacity

27 Sep 2024 Policy

Leukaemia UK calls upon government to increase blood testing capacity

Together with Leukaemia Care, we're calling on the new Secretary of State for Health and Social Care to focus on...

Leukaemia UK launches manifesto to demand better for those affected by leukaemia

13 Mar 2024 Policy

Leukaemia UK launches manifesto to demand better for those affected by leukaemia

Leukaemia UK has today launched its manifesto to demand better for those affected by leukaemia. The manifesto calls on the...